CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based ...
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.